2020
DOI: 10.1111/iej.13327
|View full text |Cite
|
Sign up to set email alerts
|

Chemical composition and bioactivity potential of the new Endosequence BC Sealer formulation HiFlow

Abstract: AimTo evaluate in a laboratory setting the effects of Endosequence BC Sealer HiFlow (Brasseler USA, Savannah, GA, USA), a novel calcium silicate‐based sealer developed for use in warm canal filling techniques, on human periodontal ligament stem cells (hPDLSCs).MethodologyEluates of EndoSequence BC Sealer HiFlow (BCHiF) (Brasseler USA), EndoSequence BC Sealer (BCS) (Brasseler USA) and AH Plus (AHP) (Dentsply DeTrey GmbH, Konstanz, Germany) were placed in contact with hPDLSCs. The characterization of the chemica… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
37
0
2

Year Published

2020
2020
2024
2024

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 46 publications
(54 citation statements)
references
References 39 publications
(38 reference statements)
2
37
0
2
Order By: Relevance
“…To the best of our knowledge, this is the first in vivo study evaluating TotalFill BC Sealer HiFlow biocompatibility in subcutaneous tissue. The present study shows that BC and HiFlow induced lower inflammatory response when compared to AH Plus, rejecting the null hypothesis and confirming that calcium-silicate based sealers present proper biological properties [ 16 , 17 ]. This arises from the basic composition of the sealers and may also be related to the presence of zirconium oxide in BC, which has been associated with lower inflammatory reaction compared to sealers with barium oxide in their composition [ 24 , 25 ].…”
Section: Discussionsupporting
confidence: 74%
See 3 more Smart Citations
“…To the best of our knowledge, this is the first in vivo study evaluating TotalFill BC Sealer HiFlow biocompatibility in subcutaneous tissue. The present study shows that BC and HiFlow induced lower inflammatory response when compared to AH Plus, rejecting the null hypothesis and confirming that calcium-silicate based sealers present proper biological properties [ 16 , 17 ]. This arises from the basic composition of the sealers and may also be related to the presence of zirconium oxide in BC, which has been associated with lower inflammatory reaction compared to sealers with barium oxide in their composition [ 24 , 25 ].…”
Section: Discussionsupporting
confidence: 74%
“…Calcium silicate-based sealers showed, in vitro, potential to stimulate osteoblastic differentiation and to promote overexpression of osteo/cementogenic genes [ 13 , 17 ]. Histologically, this capacity is evaluated by the von Kossa staining technique, which allows for the detection of calcium precipitates, in order to assess the bioactivity of these materials [ 25 ].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…To allow the use of warm obturation techniques together with calcium silicate-based sealers, a new sealer-Total Fill BC Sealer HiFlow (TFHF; FKG Dentaire, La Chaux des Fonds, Switzerland)-was recently introduced [9]. It is labelled to fulfil all requirements for a sealer to be used with warm vertical root canal filling techniques.…”
Section: Introductionmentioning
confidence: 99%